Markers of inflammation before and after curative ablation of atrial flutter

Heart Rhythm

Volumn 5, Issue 2, 2008, Pages 215-221

  Marcus, Gregory M ^a   Smith, Lisa M ^a   Glidden, David V ^b   Wilson, Emily ^a   McCabe, Jamie M ^a   Whiteman, Dean ^a   Tseng, Zian H ^a   Badhwar, Nitish ^a   Lee, Byron K ^a   Lee, Randall J ^a   Scheinman, Melvin M ^a   Olgin, Jeffrey E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ablation; Atrial arrhythmias; Atrial flutter; CRP; IL 6; Inflammation

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CATHETER ABLATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY SINUS; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FEMORAL ARTERY; FOLLOW UP; HEART ATRIUM FLUTTER; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

ATRIAL FLUTTER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CATHETER ABLATION; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TACHYCARDIA, PAROXYSMAL; TACHYCARDIA, SUPRAVENTRICULAR; TIME FACTORS;

EID: 38649140749     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2007.10.007     Document Type: Article

References (23)

1. Chugh S.S., Blackshear J.L., Shen W.K., et al. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol 37 (2001) 371-378
2. Chung M.K., Martin D.O., Sprecher D., et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104 (2001) 2886-2891
3. Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation). J Am Coll Cardiol 48 (2006) 854-906
4. Waldo A.L. The interrelationship between atrial fibrillation and atrial flutter. Prog Cardiovasc Dis 48 (2005) 41-56
5. Calkins H., Leon A.R., Deam A.G., et al. Catheter ablation of atrial flutter using radiofrequency energy. Am J Cardiol 73 (1994) 353-356
6. Saxon L.A., Kalman J.M., Olgin J.E., et al. Results of radiofrequency catheter ablation for atrial flutter. Am J Cardiol 77 (1996) 1014-1016
7. Tai C.T., Chen S.A., Chiang C.E., et al. Long-term outcome of radiofrequency catheter ablation for typical atrial flutter: risk prediction of recurrent arrhythmias. J Cardiovasc Electrophysiol 9 (1998) 115-121
8. Blomstrom-Lundqvist C., Scheinman M.M., Aliot E.M., et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias). Circulation 108 (2003) 1871-1909
9. Lee K.W., Yang Y., and Scheinman M.M. Atrial flutter: a review of its history, mechanisms, clinical features, and current therapy. Curr Probl Cardiol 30 (2005) 121-167
10. Conway D.S., Buggins P., Hughes E., et al. Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. Am Heart J 148 (2004) 462-466
11. Psychari S.N., Apostolou T.S., Sinos L., et al. Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol 95 (2005) 764-767
12. Frustaci A., Chimenti C., Bellocci F., et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96 (1997) 1180-1184
13. Kumagai K., Khrestian C., and Waldo A.L. Simultaneous multisite mapping studies during induced atrial fibrillation in the sterile pericarditis model. Insights into the mechanism of its maintenance. Circulation 95 (1997) 511-521
14. Bruins P., te Velthuis H., Yazdanbakhsh A.P., et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 96 (1997) 3542-3548
15. Aviles R.J., Martin D.O., Apperson-Hansen C., et al. Inflammation as a risk factor for atrial fibrillation. Circulation 108 (2003) 3006-3010
16. Sata N., Hamada N., Horinouchi T., et al. C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation?. Jpn Heart J 45 (2004) 441-445
17. Buob A., Jung J., Siaplaouras S., et al. Discordant regulation of CRP and NT-proBNP plasma levels after electrical cardioversion of persistent atrial fibrillation. Pacing Clin Electrophysiol 29 (2006) 559-563
18. Marcus G.M., and Sung R.J. Antiarrhythmic agents in facilitating electrical cardioversion of atrial fibrillation and promoting maintenance of sinus rhythm. Cardiology 95 (2001) 1-8
19. Page R.L., Wilkinson W.E., Clair W.K., et al. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 89 (1994) 224-227
20. Morady F. Catheter ablation of supraventricular arrhythmias: state of the art. J Cardiovasc Electrophysiol 15 (2004) 124-139
21. Satoh M., Nakamura M., Akatsu T., et al. C-reactive protein co-expresses with tumor necrosis factor-alpha in the myocardium in human dilated cardiomyopathy. Eur J Heart Fail 7 (2005) 748-754
22. Palmieri E.A., Benincasa G., Di Rella F., et al. Differential expression of TNF-alpha, IL-6, and IGF-1 by graded mechanical stress in normal rat myocardium. Am J Physiol Heart Circ Physiol 282 (2002) H926-H934
23. Shah S.J., Marcus G.M., Gerber I.L., et al. High-sensitivity C-reactive protein and parameters of left ventricular dysfunction. J Card Fail 12 (2006) 61-65